- Home
- NDRA vs CMND Comparison
NDRA vs CMND Comparison
Compare NDRA & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- CMND
- Stock Information
- Founded
- NDRA 2007
- CMND 2017
- Country
- NDRA United States
- CMND Canada
- Employees
- NDRA N/A
- CMND N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- NDRA Health Care
- CMND Health Care
- Exchange
- NDRA Nasdaq
- CMND Nasdaq
- Market Cap
- NDRA 5.1M
- CMND 5.5M
- IPO Year
- NDRA 2017
- CMND N/A
- Fundamental
- Price
- NDRA $4.54
- CMND $1.34
- Analyst Decision
- NDRA Strong Buy
- CMND
- Analyst Count
- NDRA 1
- CMND 0
- Target Price
- NDRA $14,000.00
- CMND N/A
- AVG Volume (30 Days)
- NDRA 709.8K
- CMND 160.9K
- Earning Date
- NDRA 11-15-2024
- CMND 11-26-2024
- Dividend Yield
- NDRA N/A
- CMND N/A
- EPS Growth
- NDRA N/A
- CMND N/A
- EPS
- NDRA N/A
- CMND N/A
- Revenue
- NDRA N/A
- CMND N/A
- Revenue This Year
- NDRA N/A
- CMND N/A
- Revenue Next Year
- NDRA N/A
- CMND N/A
- P/E Ratio
- NDRA N/A
- CMND N/A
- Revenue Growth
- NDRA N/A
- CMND N/A
- 52 Week Low
- NDRA $4.41
- CMND $0.92
- 52 Week High
- NDRA $4,882.50
- CMND $6.80
- Technical
- Relative Strength Index (RSI)
- NDRA 31.46
- CMND 44.72
- Support Level
- NDRA $5.23
- CMND $1.33
- Resistance Level
- NDRA $8.80
- CMND $1.58
- Average True Range (ATR)
- NDRA 1.58
- CMND 0.11
- MACD
- NDRA -0.06
- CMND -0.01
- Stochastic Oscillator
- NDRA 1.73
- CMND 4.00
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.